Spyke

Posts

youshouldknow·You Should KnowbyWillyWonksters

YSK: Loudspeaker quality can be more reliably estimated with a set of objective measurements called a Spinorama than by reading subjective reviews

Why: You can find better sound for less money if you learn how to read a Spinorama.

To learn how this scientific method was developed and why it is so much better than subjective reviews, I highly recommend listing to this talk by Dr. Floyd Toole.

https://www.avsforum.com/threads/how-to-choose-a-loudspeaker-what-the-science-shows.3038828/Open linkView original on lemmy.world
127

Johnson and Johnson hold millions of lives hostage: restricting the distribution of life saving generic drug

“Multidrug resistant tuberculosis is a growing threat, and bedaquiline is essential to curing it. Generic bedaquiline will drive down the cost of the drug by over 60%, allowing far more communities to access and distribute treatment. Evergreening the patent will cost so many lives over the next four years, which Johnson & Johnson knows. They must drop their efforts to enforce the secondary patents.”

"Tell Johnson and Johnson that evergreening their patent on bedaquiline, which will deny millions of people access to live-saving treatment, is a violation of their corporate credo: https://secure.ethicspoint.com/domain… Tell them on twitter: https://twitter.com/JNJNews and https://twitter.com/JNJGlobalHealth Tell them on facebook: https://www.facebook.com/jnj/ Tell them on instagram: https://www.instagram.com/jnj/?hl=en And tell them wherever else you can. Tell your friends. Tell your family. Tell the Internet. This must not be allowed to happen.

Big thanks to TB expert Dr. Carole Mitnick and MSF’s Christophe Perrin for helping me to understand the complexities of drug patents!"

View original on lemmy.world
84
world·World NewsbyWillyWonksters

Johnson and Johnson attempts to sacrifice millions of lives by restricting life saving tuberculosis drug

"Multidrug resistant tuberculosis is a growing threat, and bedaquiline is essential to curing it. Generic bedaquiline will drive down the cost of the drug by over 60%, allowing far more communities to access and distribute treatment. Evergreening the patent will cost so many lives over the next four years, which Johnson & Johnson knows. They must drop their efforts to enforce the secondary patents."

"Tell Johnson and Johnson that evergreening their patent on bedaquiline, which will deny millions of people access to live-saving treatment, is a violation of their corporate credo: https://secure.ethicspoint.com/domain... Tell them on twitter: https://twitter.com/JNJNews and https://twitter.com/JNJGlobalHealth Tell them on facebook: https://www.facebook.com/jnj/ Tell them on instagram: https://www.instagram.com/jnj/?hl=en And tell them wherever else you can. Tell your friends. Tell your family. Tell the Internet. This must not be allowed to happen.

Big thanks to TB expert Dr. Carole Mitnick and MSF's Christophe Perrin for helping me to understand the complexities of drug patents!"

View original on lemmy.world
502

You reached the end